Strata Critical Medical, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.2% | 81.0% | 80.3% | 75.9% | 73.5% | 76.8% | 77.9% | 74.9% | 76.4% | 82.5% | 79.0% | 79.0% | 79.4% | |
| 21.8% | 19.0% | 19.7% | 24.1% | 26.5% | 23.2% | 22.1% | 25.1% | 23.6% | 17.5% | 21.0% | 21.0% | 20.6% | |
| 1.5% | 2.1% | 1.3% | 1.4% | 1.1% | 1.4% | 1.5% | 1.3% | 0.9% | 2.5% | 1.7% | 1.4% | 1.7% | |
| 27.0% | 86.9% | 33.4% | 37.0% | 27.3% | 34.9% | 31.9% | 28.4% | 33.1% | 25.2% | 23.2% | 12.2% | 22.5% | |
| 32.2% | 94.0% | 38.8% | 42.0% | 31.2% | 38.6% | 36.0% | 32.0% | 35.0% | 27.1% | 25.4% | 28.4% | 28.5% | |
| -10.4% | -75.1% | -19.2% | -17.9% | -4.7% | -15.4% | -14.0% | -7.0% | -11.4% | -9.6% | -4.4% | -7.5% | -8.0% | |
| 0.6% | -73.6% | -8.4% | -16.6% | -2.8% | -18.2% | -6.5% | -5.3% | -19.6% | -8.1% | 3.6% | -14.5% | -9.0% | |
| 0.2% | -2.2% | -0.2% | 0.1% | -0.2% | -0.2% | 0.0% | 0.0% | -131.6% | 5.2% | 0.4% | – | – | |
| 0.4% | -71.5% | -8.2% | -16.7% | -2.6% | -18.0% | -6.4% | -5.3% | 116.5% | -13.2% | 3.2% | -14.5% | 15.7% | |
| 3.2% | -69.8% | -5.3% | -14.3% | -1.1% | -15.4% | -3.3% | -2.7% | -16.1% | -0.8% | 1.7% | -2.8% | -3.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.